~~<i id='3B7C8620A5'><strike id='3B7C8620A5'><tt id='3B7C8620A5'><pre id='3B7C8620A5'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

author：fashion 2025-08-12 08:26:05 - browse：5

An FDA sign — health policy coverage from STAT — Sarah Silbiger/Getty Images

WASHINGTON — There’s about to be a new acronym in town.

The Food and Drug Administration is in the final stages of cementing sweeping changes to the Office of Regulatory Affairs, which oversees inspections and compliance for all its regulated products, according to three people familiar with the planning.

That overhaul includes a new name: Meet the Office of Inspections and Investigations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Erich Jarvis studies song birds to learn about human stuttering

Wikipedia

focus

hotspot

focus

leisure time

LISELOTTESABROE/Scanpix/AFPviaGettyImagesLONDON—NovoNordisksaidMondayitwouldacquiretheGermanfirmCard

WSS

Asbestos ban is immediate, but health effects will linger for decades

Pfizer, Moderna say biotech, pharma drug development is a sprint

Drone hits Crimean ammunition depot as strikes kill, wound civilians and journalists in Ukraine

Statins reduce cardiovascular risk in people living with HIV

Transgender women dream of pregnancy via uterus transplants

What Henrietta Lacks's story taught me about my role as a doctor

entertainment

entertainment

Wikipedia

Drug repurposing or repositioning? The language matters

U.K. officials, researchers try to ease path for bespoke genetic treatments

Wildfire smoke exposes gaps in outdoor worker protections

Diabetes management: Digital health tools fall short, study says

Trump demands the U.S. pay no more for drugs than other countries … again

This gene therapy has record $4.25 million price. It's saved children.

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Yancopoulos of Regeneron works to expand Dupixent success

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Bring on the sabbaticals for nurses

focus

Yancopoulos of Regeneron works to expand Dupixent success

Diabetes management: Digital health tools fall short, study says

FAMU bans football players from facility after release of rap video shot in team's locker room

With Wegovy coverage, Medicare patients may face high costs

Pfizer, Moderna say biotech, pharma drug development is a sprint

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

focus

hotspot

focus

leisure time